Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Plus500 posts solid H1 results amid ongoing strategic expansion

(Sharecast News) - Fintech business Plus500 posted a solid set of H1 results on Monday, with strategic expansion and product diversification helping it maintain momentum across its trading platform business. Revenues rose 4% year-on-year to $415.1m, while underlying earnings ticked up 1% to $185.1m. EBITDA margins dipped slightly from 46% to 45%, reflecting increased investment in growth initiatives.

Plus500 said active customer numbers grew 2% to 179,931, with average revenue per user up 2% to $2,307. Acquisition costs per customer fell 17% to $1,237, supporting profitability.

The FTSE 250-listed group also announced an additional $165m in shareholder returns, bringing total buybacks for FY25 to $200m. Plus500 has now repurchased roughly 38% of its shares since its inception.

Plus 500 also noted that operational highlights included new regulatory licences in Canada and the UAE, a clearing membership with ICE Clear US, and the conditional acquisition of Mehta Equities in India.

Chief executive David Zruia said: "In the first half of the year, the strength of Plus500's globally diversified multi-asset offering was again evidenced by our accelerated operational, financial and strategic results. We delivered great progress during H1 2025 in further diversifying our business and strengthening our operating model.

"We look to the second half of the year and beyond with confidence."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Culture Secretary 'minded to intervene' in Sky-ITV deal
(Sharecast News) - Culture secretary Lisa Nandy on Thursday revealed that she is "minded to intervene" in Sky's proposed takeover of ITV's media and entertainment activities, suggesting possible legislation of the streaming industry may be needed.
AstraZeneca enters into strategic drug discovery deal with AI biotech Insitro
(Sharecast News) - AstraZeneca said on Thursday that it will pay up to $1.86bn to enter a new strategic drug discovery collaboration and licensing agreement with Califiornia-based AI biotech firm Insitro.
Berenberg lifts target price on Discoverie following H1 update
(Sharecast News) - Analysts at Berenberg lifted their target price for DiscoverIE from 1,050p to 1,100p on Thursday, citing sustained organic momentum, a strengthening order book and earnings running ahead of expectations.
Friday preview: Man Group update, eurozone inflation eyed
(Sharecast News) - Friday will mark a fairly quiet end to a busy week that saw the release of a slew of US bank earnings.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.